PRELUDE CAPITAL MANAGEMENT, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 155 filers reported holding CARA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,000
-83.3%
93
-80.6%
0.00%
Q4 2018$6,0000.0%479
+19.8%
0.00%
-100.0%
Q2 2017$6,000
-96.5%
400
-97.8%
0.00%
-95.2%
Q4 2016$172,000
+473.3%
18,521
+278.0%
0.02%
+425.0%
Q1 2016$30,000
-64.3%
4,900
-2.0%
0.00%
-69.2%
Q4 2015$84,000
+71.4%
5,000
+47.1%
0.01%
+85.7%
Q3 2015$49,0003,4000.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders